Laboratori 2022/2023 - Immunologia e Oncologia di Base e Applicate

Di seguito è possibile visionare l’elenco dei Supervisors (e i link ai rispettivi CV) e i progetti presentati per l' a.a. 2022/2023 all'interno del curriculum in Immunologia e Oncologia di Base e Applicate

5 BORSE A PROGETTO:

Borsa a progetto BAIO1: CASUCCI MONICA

Unit: Innovative Immunotherapies

BAIO1: Dissecting the pathophysiology of CAR-T cell related neurotoxicity to identify new actionable targets

Borsa a progetto BAIO2: SESSA ALESSANDRO

Unit: Stem Cells & Neurogenesis

BAIO2: Validation of artificial epigenetic silencers to reduce GBM in immunocompetent mouse model

Borsa a progetto BAIO3: UNGARO FEDERICA

Unit: Division of Immunology, Department of Gastroenterology

BAIO3: The role of MFSD2A in the resolution of colorectal cancer-promoting inflammation: implications for innovative therapies

Borsa a progetto BAIO4: STEFANO CASCINU

Unit: Medical Oncology

Finanziata su fondi ripartiti ai sensi del DM del 9 aprile 2022 n. 351 (M4C1 – Inv. 4.1 - Ricerca PNRR)

BAIO4: AI-HOPE Lung cancer: building a predictive tool for metastatic lung cancer

Borsa a progetto BAIO5: KUKA MIRELA

Unit: Dynamics of Immune Responses

BAIO5:In depth characterization of monocyte-B cell interactions in infection and cancer

BIANCHI MARCO

Unit: Chromatin Dynamics

CXCR4-mediated antitumor immunization

CENCI SIMONE

Unit: Age Related Diseases

Dissecting a novel mitochondrial vulnerability against multiple myeloma

DE CURTIS IVAN

Unit: Cell Adhesion

Mechanisms of regulation of a molecular network promoting cell invasion

DELLABONA PAOLO

Unit: Experimental Immunology

Functional enhancement of innate-like T cells by genetic engineering for the adoptive immunotherapy of metastatic cancers

FOUSTERI GEORGIA

Unit: Regulation of Adaptive Immunity

Project 1: Primary immunodeficiencies: follicular helper and follicular regulatory T cells as disease biomarkers Project 2: Immune therapy with regulatory T cells to establish tolerance in T1D

FRANCO IRENE

Unit: Cystic Kidney Disorders 

Somatic mutation mechanisms in pre-malignant kidney and their role in tumor initiation

GHIA PAOLO

Division: Experimental Oncology-B-cell Neoplasia B cell Neoplasia 

Project 1: Mechanisms of genetic and functional resistance to BTK inhibitors in CLL Project 2: Unravelling genetic intratumor B lymphocyte heterogeneity of chronic lymphocytic leukemia

GREGORI SILVIA

Unit: Mechanisms of Peripheral Tolerance

Define the immune drives of chronic inflammation and early onset of of comorbidities in idiopathic infertile men

MONDINO ANNA

Unit: Lymphocyte Activation

TCR/CAR T cells and radiotherapy: time to team up against solid tumors

MUZIO MARTA

Unit: Cell Signaling

Project 1: Exploring NFKBIZ-centered pathways in normal and malignant B-cells Project 2: Dissecting and targeting NFAT signaling in chronic lymphocytic leukemia

OSTUNI RENATO

Unit: Genomics of the innate immune system

Spatial diversity of tumor-associated macrophages

PETRELLI ALESSANDRA

Unit: Diabetes Research Institute - Tissue & Systemic Immunity Lab embedded in the Beta Cell Biology Unit

Investigation of CD8 T cell-mediated mechanisms of insulin-resistance in human obesity and type 2 diabetes

POLI GUIDO

Unit: Human Immuno-Virology (H.I.V.)

Role of M1/M2 Polarization of Human Macrophages in Pathogenic RNA Virus Infection

SCIELZO CRISTINA 

Unit: Malignant B cells Biology and 3D modelling

3D modelling of non-functioning neuroendocrine pancreatic neoplasms for personalized medicine

SITIA GIOVANNI

Unit: Experimental hepatology

Development of hyaluronan-based (HA) hydrogels for peri-operative immunotherapies

TACCHETTI CARLO

Unit: CIS_Experimental Imaging Center

Unraveling the role of Integrated Stress Response signaling in metastatic breast cancer mitochondrial bioenergetics and heterogeneity

TONON GIOVANNI

Unit: Functional Genomics of Cancer Unit 

Project 1: UNRAVELING THE COOPERATIVE STRATEGIES OF CANCER CELLS Project 2: Dissolving chromatin scars to restore cancer sensitivity to therapy

VAGO RICCARDO

Unit: Immunogenetics, Leukemia Genomics and Immunobiology

Analysis of extracellular vesicle-carried factors leading to cancer occurrence and progression

VENEREAU EMILIE

Unit: Tissue Regeneration & Homeostasis

Targeting of HMGB1 recycling as an innovative therapeutic strategy to fight cancer